Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling...
GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal p...
Dublin, March 19, 2025 (GLOBE NEWSWIRE) — The “Spinal Fusion Device Market by Product Type, Surgery ...
GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger....
GMED's strong synergies from the NuVasive merger and robust performance in the musculoskeletal solut...